1 | Authorization Document (POA) | 20 May 1998 |
10 | Note Sheet | 05 Mar 2003 |
11 | Journal Copy | 29 Jun 2003 |
12 | Certificate | 28 Jan 2004 |
13 | Assignment Deed | 29 Sep 2006 |
14 | Authorization Document (POA) | 09 Nov 2006 |
15 | TM-24 | 27 Nov 2006 |
16 | Priority Document | 08 Feb 2007 |
17 | Letters related to TOP | 24 Apr 2018 |
18 | Letters related to TOP | 24 Apr 2018 |
19 | Hearing Notice | 10 Aug 2024 |
2 | File Cover | 06 Dec 1999 |
2 | TM-1 | 06 Dec 1999 |
20 | Hearing Notice | 17 Oct 2024 |
3 | File Cover | 06 Dec 1999 |
3 | TM-1 | 06 Dec 1999 |
4 | Examination Report | 24 Jan 2002 |
5 | Reply to Exam Report (MIS-R) | 30 Jan 2002 |
6 | Assignment Deed | 27 Mar 2002 |
7 | Power of Attorney | 06 Aug 2002 |
8 | Covering Letter | 21 Sep 2002 |
9 | TM-16 | 21 Oct 2002 |
1 | PR Hearing Notice for : 889979 | 18660721 | 08 Aug 2024 |
The application for Auronim md was made on 06 December 1999.
The trademark applicant for Auronim md is AUROBINDO PHARMA.
Auronim md is applied in class(es) 5.
Application for Auronim md is on Removed stage.
Application Id allotted to Auronim md is 889979.
Trademark agent or attorney for the application is Tricons.
Auronim md filed with the Intellectual property office as a WORD.